EcoDrugPlus

Thymidine Phosphorylase

Ensembl ID : ENSPNYG00000011334
Gene Symbol: TYMP
4 Cross references
171 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSPNYG00000000985
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSPNYG00000000955
Gene Symbol: THRB
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSPNYG00000005105
Gene Symbol: TRHR
1 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor-Like

Ensembl ID : ENSPNYG00000006378
Gene Symbol: LOC102199955
3 Cross references
193 Possible Orthologues:

Tissue Factor-Like

Ensembl ID : ENSPNYG00000010085
Gene Symbol: LOC102193775
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSPNYG00000011585
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSPNYG00000011635
Gene Symbol: TLR8
4 Cross references
180 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSPNYG00000005939
Gene Symbol: LOC102201828
2 Cross references
163 Possible Orthologues:

Trace Amine-Associated Receptor 13c-Like

Ensembl ID : ENSPNYG00000005189
Gene Symbol: LOC102215785
2 Cross references
121 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSPNYG00000005497
Gene Symbol: TGFBR1
3 Cross references
202 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSPNYG00000001297
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).